129 related articles for article (PubMed ID: 38305061)
1. Malignant upgrade rate and associated clinicopathologic predictors for concordant intraductal papilloma without atypia: A systematic review and meta-analysis.
Keating N; Cevik J; Hopkins D; Lippey J
J Surg Oncol; 2024 May; 129(6):1025-1033. PubMed ID: 38305061
[TBL] [Abstract][Full Text] [Related]
2. Upgrade rate of intraductal papilloma without atypia on breast core needle biopsy: A clinical, radiological and pathological correlation study.
Genco IS; Tugertimur B; Manolas PA; Hasanovic A; Hajiyeva S
Am J Surg; 2020 Sep; 220(3):677-681. PubMed ID: 32007236
[TBL] [Abstract][Full Text] [Related]
3. Upgrade rates of intraductal papilloma with and without atypia diagnosed on core needle biopsy and clinicopathologic predictors.
Corbin H; Bomeisl P; Amin AL; Marshall HN; Gilmore H; Harbhajanka A
Hum Pathol; 2022 Oct; 128():90-100. PubMed ID: 35863513
[TBL] [Abstract][Full Text] [Related]
4. The Management Strategy of Benign Solitary Intraductal Papilloma on Breast Core Biopsy.
Ko D; Kang E; Park SY; Kim SM; Jang M; Yun B; Chae S; Jang Y; Kim HJ; Kim SW; Kim EK
Clin Breast Cancer; 2017 Aug; 17(5):367-372. PubMed ID: 28438672
[TBL] [Abstract][Full Text] [Related]
5. Breast intraductal papillomas without atypia in radiologic-pathologic concordant core-needle biopsies: Rate of upgrade to carcinoma at excision.
Pareja F; Corben AD; Brennan SB; Murray MP; Bowser ZL; Jakate K; Sebastiano C; Morrow M; Morris EA; Brogi E
Cancer; 2016 Sep; 122(18):2819-27. PubMed ID: 27315013
[TBL] [Abstract][Full Text] [Related]
6. Papillary Breast Lesions: Association with Malignancy and Upgrade Rates on Surgical Excision.
Tran HT; Mursleen A; Mirpour S; Ghanem O; Farha MJ
Am Surg; 2017 Nov; 83(11):1294-1297. PubMed ID: 29183534
[TBL] [Abstract][Full Text] [Related]
7. Upgrade rate of intraductal papilloma diagnosed on core needle biopsy in a single institution.
Lin LH; Ozerdem U; Cotzia P; Lee J; Chun J; Schnabel F; Darvishian F
Hum Pathol; 2021 Apr; 110():43-49. PubMed ID: 33159966
[TBL] [Abstract][Full Text] [Related]
8. Excision recommended in high-risk patients: Revisiting the diagnosis of papilloma on core biopsy in the context of patient risk.
Chen YA; Mack JA; Karamchandani DM; Zaleski MP; Xu L; Dodge DG; Chetlen AL
Breast J; 2019 Mar; 25(2):232-236. PubMed ID: 30697873
[TBL] [Abstract][Full Text] [Related]
9. Does previous history of cancer or atypia predict histologic upgrade for pure intraductal papillomas diagnosed via core biopsy? A study of 490 cases at a single institution.
Alberty-Oller JJ; Reyes S; Moshier E; Ru M; Weltz S; Santos A; Pisapati K; Port E; Jaffer S
Cancer Rep (Hoboken); 2022 Mar; 5(3):e1481. PubMed ID: 34729946
[TBL] [Abstract][Full Text] [Related]
10. Papillary lesions of the breast: To excise or observe?
Khan S; Diaz A; Archer KJ; Lehman RR; Mullins T; Cardenosa G; Bear HD
Breast J; 2018 May; 24(3):350-355. PubMed ID: 28845569
[TBL] [Abstract][Full Text] [Related]
11. Upgrade Rate and Predictive Factors for Breast Benign Intraductal Papilloma Diagnosed at Biopsy: A Meta-Analysis.
Zhang X; Liu W; Hai T; Li F
Ann Surg Oncol; 2021 Dec; 28(13):8643-8650. PubMed ID: 34331160
[TBL] [Abstract][Full Text] [Related]
12. Management of intraductal papilloma without atypia of the breast diagnosed on core biopsy: Size and sampling matter.
Symbol B; Ricci A
Breast J; 2018 Sep; 24(5):738-742. PubMed ID: 29687535
[TBL] [Abstract][Full Text] [Related]
13. Non-mass-associated intraductal papillomas: is excision necessary?
Weisman PS; Sutton BJ; Siziopikou KP; Hansen N; Khan SA; Neuschler EI; Rohan SM; Franz JM; Sullivan ME
Hum Pathol; 2014 Mar; 45(3):583-8. PubMed ID: 24444467
[TBL] [Abstract][Full Text] [Related]
14. Intraductal papillary lesions of the breast: clinical and pathological correlation.
Shouhed D; Amersi FF; Spurrier R; Dang C; Astvatsaturyan K; Bose S; Phillips E
Am Surg; 2012 Oct; 78(10):1161-5. PubMed ID: 23025963
[TBL] [Abstract][Full Text] [Related]
15. Multidisciplinary Review of Intraductal Papilloma of the Breast can Identify Patients who may Omit Surgical Excision.
Abbassi-Rahbar S; Sack S; Larson KE; Wagner JL; Kilgore LJ; Balanoff CR; Winblad OD; Amin AL
Ann Surg Oncol; 2021 Oct; 28(10):5768-5774. PubMed ID: 34338925
[TBL] [Abstract][Full Text] [Related]
16. Should we excise? Are there any clinical or histologic features that predict upgrade in papillomas, incidental or non-incidental?
Zaleski M; Chen YA; Chetlen AL; Mack J; Xu L; Dodge DG; Karamchandani DM
Ann Diagn Pathol; 2018 Aug; 35():62-68. PubMed ID: 29793212
[TBL] [Abstract][Full Text] [Related]
17. High-Risk Lesions Detected by MRI-Guided Core Biopsy: Upgrade Rates at Surgical Excision and Implications for Management.
Michaels AY; Ginter PS; Dodelzon K; Naunheim MR; Abbey GN
AJR Am J Roentgenol; 2021 Mar; 216(3):622-632. PubMed ID: 33439046
[No Abstract] [Full Text] [Related]
18. Surgical follow-up and clinical presentation of 142 breast papillary lesions diagnosed by ultrasound-guided core-needle biopsy.
Rizzo M; Lund MJ; Oprea G; Schniederjan M; Wood WC; Mosunjac M
Ann Surg Oncol; 2008 Apr; 15(4):1040-7. PubMed ID: 18204989
[TBL] [Abstract][Full Text] [Related]
19. Intraductal papillomas on core biopsy can be upgraded to malignancy on subsequent excisional biopsy regardless of the presence of atypical features.
Shiino S; Tsuda H; Yoshida M; Jimbo K; Asaga S; Hojo T; Kinoshita T
Pathol Int; 2015 Jun; 65(6):293-300. PubMed ID: 25801805
[TBL] [Abstract][Full Text] [Related]
20. Are we overtreating intraductal papillomas?
Kiran S; Jeong YJ; Nelson ME; Ring A; Johnson MB; Sheth PA; Ma Y; Sener SF; Lang JE
J Surg Res; 2018 Nov; 231():387-394. PubMed ID: 30278958
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
